Table 3.

Effect of TTEP on the T lymphocyte subgroups of BCG/LPS induced live injury ($\overline{x}\pm \mathrm{s}$, n=10).

Group	CD3+ (%)	CD4+ (%)	CD8+ (%)	CD4+ / CD8+ (%)
Control	76.1 ± 6.4	52.5 ± 6.0	24.9 ± 6.8	2.11 ± 0.42
Model	38.6 ± 4.2##	32.6 ± 5.8##	45.7 ± 7.9#	0.71 ± 0.08##
Bifendate	62.3 ± 7.5∗∗	43.7 ± 8.1∗∗	28.6 ± 7.3∗	1.52 ± 0.41∗∗
TFEP 50 mg/Kg	43.5 ± 5.6	35.5 ± 5.1	36.7 ± 8.3	0.96 ± 0.17∗
100 mg/Kg	56.4 ± 7.3∗	39.1 ± 6.3∗	32.3 ± 6.7∗	1.21 ± 0.36∗∗
200 mg/Kg	67.7 ± 5.4∗∗	45.0 ± 7.4∗∗	27.1 ± 5.8∗	1.66 ± 0.49∗∗

Anticoagulated blood was treated with erythrocyte lysate to get the lymphocyte suspension and then incubated with CD3+, CD4+, and CD8+ antibody before analysis with flow cytometry. ^∗P < 0.05, ^∗∗P < 0.01 compared with the model group; ^#P<0.05, ^##P<0.01 compared with the control group.